Barclays keeps Buy rating as JBS stock target stays at USD 20.00

Published on 10/16/2026 at 05:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Barclays kept its Buy rating and set a USD 20.00 target on October 14, 2026. JBS stock reports Q3 results on November 9, 2026.

Analyst view and reporting dates

Barclays maintained its Buy rating and set a USD 20.00 target on October 14, 2026.
JBS reported USD 23.90 billion in second-quarter revenue on October 8, 2026, up 14.00 percent year over year.
JBS is scheduled to report third-quarter results on November 9, 2026.

JBS, BRJBSSACNOR8, Illustration mit AI erstellt.

JBS (BRJBSSACNOR8) has a USD 20.00 analyst target after Barclays maintained its Buy rating on October 14, 2026. The call followed a difficult second quarter, when revenue grew but the company posted a net loss.

According to Markets Insider, Barclays analyst Benjamin Theurer kept the Buy rating and set the USD 20.00 target on October 14, 2026. The target is one of the latest published valuation markers for the company.

Three dates reshape the picture

JBS moved into a new corporate structure on September 21, 2026, when its Brazilian subsidiary began the process of canceling its public-company registration; the group remained listed through JBS N.V. on the NYSE, according to G1. On October 8, 2026, JBS reported second-quarter revenue of USD 23.90 billion, up 14.00 percent from a year earlier, but a USD 102.10 million net loss, reported El Fondo. Barclays then reaffirmed its USD 20.00 target on October 14, 2026.

What does the target mean for JBS stock?

The analyst view contrasts with the quarter's earnings pressure. JBS generated adjusted net profit of USD 218.30 million in the second quarter, down 62.30 percent year over year, while adjusted EBITDA reached USD 1.26 billion, according to El Fondo. The same report said first-half revenue reached USD 45.51 billion and net debt to EBITDA rose to 3.10 times from 2.27 times a year earlier.

JPMorgan had raised its price target to USD 18.00 from USD 17.50 on October 9, 2026, while maintaining an Overweight rating, according to MarketBeat. That target is below Barclays' USD 20.00 level, showing a positive but not uniform analyst range.

Next report date is November 9

JBS is scheduled to report third-quarter results on November 9, 2026, according to Gekko. The next report will test whether revenue growth can offset the pressure visible in second-quarter earnings and leverage.

Valuation rests on the next earnings test

JBS has a market capitalization of USD 28.2 billion as of October 15, 2026. Its broad protein portfolio and the USD 20.00 Barclays target provide support for the valuation case, while the USD 102.10 million quarterly loss and 3.10 times net debt-to-EBITDA ratio remain material counterweights.